Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MicrobesNG is a UK-based microbial sequencing company focused on whole-genome sequencing, metagenomics, and associated bioinformatics services for researchers in academia, clinical microbiology, and industry. The company operates a service-based platform rather than a therapeutic drug pipeline, offering short-read, long-read, and hybrid microbial genome sequencing as well as metagenomics workflows. Its services include sample handling, DNA extraction for certain sample types, sequence generation, assembly, taxonomic analysis, and data delivery through a customer-facing project system. MicrobesNG appears to be an active private company headquartered in Birmingham and has close ties to the University of Birmingham through its scientific leadership and origins. The business is best characterized as a microbial genomics service provider and sequencing CRO rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MicrobesNG.